10.1016/j.nbd.2021.105510 Neurobiol
M.Martnez-LpezA.et al (2015)
Those included various baseline characteristic including demographics (age, gender, race), comorbidities (e.g., liver diseases, chronic lower respiratory diseases, diabetic complications, obesity and neoplasm), medications (e.g., insulin, metformin, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), tacrolimus, cyclosporine, mycophenolate mofetil (MMF), and corticosteroids), as well as laboratory tests and physical findings (e.g., hemoglobin, glycated hemoglobin (HbA1c) levels, lipid profile, estimated glomerular filtration rate (eGFR) and systolic blood pressure (SBP))
Graphic by Clara Turnage/University Marketing and Communications By Clara Turnage Campus Office, Department or Center Published July 20, 2026
Many patients using tirzepatide see reductions in total cholesterol, LDL cholesterol (bad cholesterol), and triglycerides, along with potential increases in HDL cholesterol (good cholesterol)